baber/WOPTO huggingface dataset:
Patent NZ-587313-A (NZ)
Title: Leather tanning process based on the recycling of poly hydroxyl alkyl phosphine and its derivatives
Inventor: YANG YINGYONG
IPC: C14C3/02
Filed: 2009-02-24
Abstract: Disclosed is a leather tanning process comprising the steps of: A) - preparing a tanning initial liquid of tanning agent made of poly hydroxyl alkyl phosphine and its derivatives then adding a stabilizer to the tanning initial liquid; said stabilizer is a mixture that contains surface active agent, poly hydroxyl compound, phosphate salt, preservatives in an amount of 0.1-2 percent of pickling skin weight or 0.1-3 gram/liter of tanning bath liquid; adding a buffer agent to the tanning initial liquid in an amount of 0.1-3 percent of pickling skin weight and 0.1-3 gram/liter of tanning bath liquid; wherein the tanning initial liquid contains at least one type of poly hydroxyl alkyl phosphine and its derivatives in a concentration of 0.4-5.0 percent of pickling skin weight, preferably 1.0-5.0 percent of pickling skin weight, or 0.4-7 gram/liter of tanning bath liquid, preferably 1-7 gram/liter oftanning bath liquid; and B) - adding the pickling skin to the tanning initial liquid, the skin being rotated 90-360 degrees, and adding alkali successively to increase the pH of the bath liquid gradually to 5-7, the skin being again rotated 60-360 degrees and taken out, after tanning is completed, washing the skin with water, and performing the routine post-tanning step, the concentration of the poly hydroxyl alkyl phosphine and its derivatives in the residual liquid being measured through iodine titration solution by using micro titration test chamber, analyzed and adjusted to the initial tanning agent content, and adjusting the pH with acidic matters between 3-5; and C) adding 0-50 percent of the stabilizer and the buffer agent in step A) to the aforesaid adjusted tanning bath liquid, the residual liquid of the completely adjusted mixture of tanning agent stabilizer and buffer agent being recycling batch wise or continuously.
Patent NZ-587411-A (NZ)
Title: Free-standing, immersible water turbine comprising an axial rotor curved away from the turbine
Inventor: BISKUP FRANK
IPC: F03B17/06
Filed: 2009-01-10
Abstract: An immersible power generation plant, driven by a tidal current, comprises a water turbine 2 in the form of an axial turbine 2 with propeller-shaped turbine blades 3.1, 3.2, 3.3 and an associated rotational axis 9, with the axial turbine 2 being fastened to a support structure 7 arranged as a tower. The axial turbine 2 is associated with a rotational plane 15 which is determined as a surface normal by the rotational axis 9 and a base point of a turbine blade. The turbine blades 3.1, 3.2, 3.3 have an airfoil profile, with the profile sections being arranged along a threading line in the direction radially to the outside with a continuously decreasing profile depth. The turbine blades 3.1, 3.2, 3.3 are arranged in such a way that the progression of the threading line of the respective profile sections projected onto the rotational plane 15 of the axial turbine 2 deviates from the radial beam 13 and is curved when projected onto a plane that is perpendicular to the rotational plane 15, so that the threading line has a directional component facing away from the support structure 7.
Patent NZ-589236-A (NZ)
Title: Conical diffuser tip
Inventor: MCKINNON AUSTIN JASON
IPC: A61M25/00
Filed: 2009-05-05
Abstract: 589236 A device (10) is disclosed for accessing the vasculature of a patient. The device comprises a catheter tube (12) and a generally conical diffuser tip (18) attached to an end of the catheter tube. The catheter tube (12) and diffuser tip (18) are in fluid communication so that an infusant may pass through the catheter tube (12) and into the diffuser tip (18) before exiting the device. A method is disclosed of using such a device (10) to reduce the recoil force of a vascular catheter during infusion.
Patent NZ-590349-A (NZ)
Title: Use of a glycomacropeptide composition for the treatment or prevention of gout
Inventor: PALMANO KAY PATRICIA
IPC: A61P19/02
Filed: 2009-10-09
Abstract: The use of glycomacropeptide for the treatment of gout. The glycomacropeptide can have SEQ ID NO: 1 or 2, or form a part of sweet whey. The glycomacropeptide can be used in a dairy composition to increase uric acid excretion.
Patent NZ-592621-A (NZ)
Title: Determining whether the teats of a milking animal have been cleaned by measuring a teat related parameter
Inventor: HOLMGREN HANS
IPC: A01J5/017
Filed: 2009-12-10
Abstract: 592621 Disclosed is a detecting arrangement for a teat cleaning device (16) including a teat cleaning cup (17) which contains the teats of milking animals (15) during the cleaning thereof. A measuring device (19) automatically measures a teat related parameter in or adjacent to the teat cleaning cup (17) from the teat at completion of a teat cleaning process. A processing device (18) is connected to the measuring device (17) and automatically compares the measured teat related parameter with a reference value. The processing device (18) then automatically determines whether the teat of the milking animal (15) has been contained in the teat cleaning cup (17) manifold during the teat cleaning process based on the comparison.
Patent NZ-594598-A (NZ)
Title: Molecules able to modulate the expression of at least a gene involved in degradative pathways and uses thereof
Inventor: BALLABIO ANDREA
IPC: A61K38/17
Filed: 2010-02-11
Abstract: Disclosed is a molecule being able to modulate the expression of at least a gene involved in degradative pathways so to enhance the cellular degradative pathways and prevent or antagonize the accumulation of toxic compounds in a cell and acting on a CLEAR element. Preferred molecules are: the TFEB protein, synthetic or biotechnological functional derivative thereof; chimeric molecule comprising the TFEB protein, synthetic or biotechnological functional derivative thereof; modulator of the TFEB protein activity and/or expression level. The molecule may be used in the treatment of neurodegenerative and/or lysosomal storage disorders.
Patent NZ-597852-A (NZ)
Title: Grooved anode for aluminium electrolysis with groove not extending through a side face but not to a top or bottom face or to top or bottom faces only over a small length
Inventor: BERLIN GEOFFREY
IPC: C25C3/12
Filed: 2010-07-21
Abstract: The disclosure relates to a carbon anode block (13a) for a prebaked anode (4) to be used in a metal electrolysis cell (1) comprising an upper surface (24), a lower surface (23) to be arranged opposite an upper surface of a cathode (not shown) and four side surfaces (21, 22), and including at least one first groove (31) that leads onto at least one of the side surfaces, wherein the first groove has a maximum length Lmax in a plane that is parallel to the lower surface, and characterized in that the first groove does not lead onto said lower or upper surfaces, or leads onto said lower or upper surfaces over a length Lo that is less than half of the maximum length Lmax.
Patent NZ-599532-A (NZ)
Title: Pepper line smr 99-1271
Inventor: MCCARTHY WILLIAM
IPC: A01H5/08
Filed: 2011-12-02
Abstract: Provided is a pepper plant, comprising at least a first set of the chromosomes of pepper line SMR 99-1271, a sample of seed of said line having been deposited under ATCC Accession Number PTA-11518. Further provided are methods of using the line in pepper breeding.
Patent NZ-607624-A (NZ)
Title: Adenosine a1 agonists for the treatment of glaucoma and ocular hypertension
Inventor: KNORR ANDREAS
IPC: A61P27/06
Filed: 2011-08-29
Abstract: Disclosed herein is a compound of formula (I), wherein the variables are defined in the specification, and the use thereof in the treatment and/or prophylaxis of glaucoma, normotensive glaucoma, ocular hypertension and/or combinations thereof. Additionally disclosed is a medicament comprising said compound in combination with one or more further active ingredients selected from the group consisting of alpha adrenergic agonist, beta blocker and carbonic anhydrase inhibitor. In one embodiment the compound is 2-{ 4-[2-amino-6-({ [2-(4-chlorophenyl)-1,3-thiazol-4-yl]methyl} sulfanyl)-3,5-dicyanopyridin-4-yl]phenoxy} ethyl-L-lysyl-D-alaninate-dihydrochloride.
Patent NZ-607881-A (NZ)
Title: Humanized antibody against amyloid beta
Inventor: PFEIFER ANDREA
IPC: C07K16/18
Filed: 2007-07-13
Abstract: Disclosed is a antibody or a functional fragment thereof capable of specifically binding beta-amyloid peptide, wherein said antibody or functional fragment thereof comprises human-derived framework regions, and wherein said antibody or functional fragment thereof further comprises a Heavy Chain Variable Region as defined herein. Disclosed is a antibody or a functional fragment thereof capable of specifically binding beta-amyloid peptide, wherein said antibody or functional fragment thereof comprises human-derived framework regions, and wherein said antibody or functional fragment thereof further comprises a Light Chain Variable Region as defined herein. Further disclosed are artificial hybrid (bispecific) antibodies comprising two different heavy/light chain pairs and two different binding sites as defined herein.
Patent NZ-609123-A (NZ)
Title: Chromobacterium bioactive compositions and metabolites
Inventor: ASOLKAR RATNAKAR
IPC: A01N63/02
Filed: 2011-10-24
Abstract: NZ 609123 Disclosed is a method for modulating nematode infestation in a plant comprising applying to the plant and/or seeds thereof and/or substrate for growing said plant a composition derived from an isolated Chromobacterium sp. in an amount effective to modulate said nematode infestation, wherein the Chromobacterium sp. produces a compound having the structure, Chromamide A, as disclosed in the specification.
Patent NZ-609984-A (NZ)
Title: Human anti-tau antibodies
Inventor: CHEN FENG
IPC: C07K16/46
Filed: 2011-10-11
Abstract: Disclosed is an anti-tau antibody comprising CDR H1: ISAIH CDR H2: RIRSKSHNYATLYAASLKG CDR H3: LSANYDTFDY CDR L1: FGDTLPKQYTY CDR L2: KDTERPS CDR L3: LSADNSATWV and the use of the antibody to treat a neurodegenerative taupoath
Patent NZ-611896-A (NZ)
Title: Fluid connector with a hose cutting clip
Inventor: WELLS MICHAEL PAUL
IPC: F16L33/01
Filed: 2011-12-21
Abstract: A coupling for an electrically conductive hose is disclosed. The coupling includes a cutting clip (10) with a cutting end (14). The cutting end tab (14) is shaped to cut the inner layer (42) of a multiple layer fluid conveyance hose (40) when the hose (40) is installed on the connector. The cutting action by the clip (10) provides for a relatively low resistance electrical connection between an electrically conductive layer (44) of the hose and the fluid connector. This can be used to provide a signal path from a sensing element on or in the hose to a system electronic component.
Patent NZ-618829-A (NZ)
Title: Modified antibiotic peptides having variable systemic release
Inventor: HOFFMANN RALF
IPC: C12Q1/37
Filed: 2012-06-20
Abstract: Disclosed is a modified peptide containing one of the following sequences: NT-X1-D2-K3-P4-P5-Y6-L7-P8-R9-P10-X2-P12-P13-R14-X3-I16-Y17-N18-X4-CT NT-X1-D2-K3-P4-P5-Y6-L7-P8-R9-P10-X2-P12-P13-R14-X3-I16-Y17-N18-N19-X4-CT NT-X1-D2-K3-P4-P5-Y6-L7-P8-R9-P10-X2-P12-P13-R14-X3-I16-P17-N18-X4-CT X1 is a residue having a non-polar, hydrophobic side chain or an amino acid residue whose side chain is positively charged under physiological conditions, having a positive net charge or a side chain that is positively charged under physiological conditions; D2 is an aspartic acid or glutamic acid residue, K3 is a residue having a positive net charge or a side chain that is positively charged under physiological conditions, preferably lysine or arginine, X2 and X4 are selected independently of one another from residues having a positive net charge or a side chain that is positively charged under physiological conditions; X3 is a residue having a positive net charge or a side chain that is positively charged under physiological conditions or proline or a proline derivative; L7 and I16 are selected independently of one another from residues having a non-polar, hydrophhobic side chain, preferably leucine, isoleucine and valine, Y6 and Y17 are each tyrosine, R9 and R14 are each arginine, N18 and N19 are each asparagine or glutamine, P4, P5, P8, P10, P12, P13 and P17 are selected independently of one another from proline and proline derivatives or hydroxyproline and hydroxyproline derivatives, wherein P13 and R14 are optionally interchanged, and/or optionally one or two of the residues selected from D2, P4, P5, P8, P10, P12, P13, P17 and Y17 are replaced by any desired residue, NT is the free or modified N-terminus of the amino acid X1, CT is the free or modified C-terminus of the amino acid X4, characterised in that a linear or branched polyethylene glycol polymer chain is bonded to NT via a peptide linker, and wherein the peptide linker is from 3 to 8 amino acid residues long and contains at least one arginine or lysine at the C-terminus of the peptide linker, that is to say upstream of X1. Also disclosed is its use in the manufacture of a medicament for treating infections by microorganisms including bacteria and fungi.
Patent NZ-620849-A (NZ)
Title: Food based homogenizer
Inventor: MACHOVINA BRIAN LOUIS
IPC: B01F15/00
Filed: 2011-08-08
Abstract: 620849 A food homogenizer (20) is provided comprising a base (22) and a homogeniser assembly (24) removably coupled to the base. The base comprises a driving motor with a drive shaft. The homogeniser assembly comprises a homogenising chamber (50), a shredder (52), and a rotational support. The shredder is disposed within the homogenising chamber and driven by the driving motor for rotational movement about an axis. The rotational support is also provided within the homogenising chamber at a closed axial end, distal from the drive shaft. The shredder is axially supported for rotation between the drive shaft and rotational support.
Patent NZ-622044-A (NZ)
Title: Use of lipochito-oligosaccharides and/or chito-oligosaccharides in combination with phosphate-solubilizing microorganisms to enhance plant growth
Inventor: SMITH R STEWART
IPC: C05F11/08
Filed: 2012-09-14
Abstract: Disclosed are methods of enhancing plant growth, comprising a) treating plant seed with an effective amount of at least one phosphate solubilizing microorganism such as a strain of the fungus Penicillium, and b) treating the seed or plant that germinates from the seed with an effective amount of at least one lipo chitooligosaccharide (LCO) and/or at least one chitoogliosaccharide (CO), wherein upon harvesting the plant exhibits at least one of increased plant yield measured in terms of bushels/acre, increased root number, increased root length, increased root mass, increased root volume and increased leaf area, compared to untreated plants or plants harvested from untreated seed.
Patent NZ-625050-A (NZ)
Title: Meat product
Inventor: LANZRATH RUSSELL
IPC: A23L13/60
Filed: 2012-12-13
Abstract: The present disclosure provides a meat product comprising (a) uncooked meat; wherein the uncooked meat has been contacted with (b) acerola (Malpighia emarginata) berry, acerola (Malpighia emarginata) berry extract or mixtures thereof and (c) green tea (Camellia sinensis), green tea (Camellia sinensis) extract or mixtures thereof. The meat product retains its fresh colour longer.
Patent NZ-626831-A (NZ)
Title: Packaging sheet, packaging and use of such a packaging sheet
Inventor: PROVOST JEAN-JACQUES
IPC: B65D81/26
Filed: 2014-06-30
Abstract: A packing sheet (1) for packaging a cheese product. The packing sheet contains an internal membrane (5) comprising at least one internal plastic layer (7) and at least one water absorbing layer (12). The packaging sheet also comprises an external surface (10). Each internal plastic membrane has a plurality of micro-perforations (8, 9), which are arranged in a random fashion. The perforations are created in such a manner that the internal membrane has a permeability of between 5 and 500 mL/min Bendtsen. The water absorbing layer comprising a water absorbing material with a water absorption rate between 1 and 30 g/m2, as measured using the COBB test, C3600. The external surface is suitable for printing on. The packing sheet draws water droplets that form on the external surface of the cheese and absorbs them. This action extends the conservation time of the cheese, especially Camembert type soft cheese.
Patent NZ-627799-A (NZ)
Title: Dpf system for an engine generator
Inventor: SEIJI MATSUO
IPC: F01N3/025
Filed: 2014-07-24
Abstract: A DPF system for an engine generator (E, G) that performs a recovery process on a filter (DPF) is disclosed. The system is provided to remove particulate matter generated by combustion of fuel when an amount of the particulate matter in the DPF exceeds a predetermined value. The engine generator (E, G) performing the recovery process by carrying out an automatic recovery operation to raise a temperature of exhaust gas to combust the particulate matter. The system comprising: a dummy load (L) connected to the engine generator when necessary; and control device (ECU) for allowing the engine to perform a recovery preparation operation in such a manner that, once the amount of the particulate matter exceeds the predetermined value. The recovery operation is performed when the temperature of exhaust gas reaches a reference temperature, and the dummy load is connected to the generator to raise the temperature of exhaust gas when the temperature thereof fails to reach the reference temperature.
Patent NZ-700397-A (NZ)
Title: Block copolymers for stable micelles
Inventor: SILL KEVIN
IPC: C08G69/40
Filed: 2013-03-15
Abstract: The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and micelles comprising the same. In particular, the invention relates to a micelle comprising a triblock copolymer, wherein said micelle has a drug-loaded inner core, a crosslinked outer core, and a hydrophilic shell, wherein the triblock copolymer is of formula VII. The micelles of the invention are useful as drug delivery vehicles.
Patent NZ-704860-A (NZ)
Title: Light and integrated junction system of the walls of a collapsible container
Inventor: PEDRO CHINNI VERGOTTINI
IPC: B65D6/26
Filed: 2015-03-04
Abstract: A junction system for joining a first wall and a second wall of a foldable container is provided. The junction system comprises a column comprising a hollow cylindrical body which is fixed with the first wall. A first closure means is fixed to the column such that the first closure means and the column are formed together in an integrated manner and in the same material. The first closure means extends outwardly from the column. The junction system further comprises a second closure means fixed to the second wall such that the second closure means and the second wall are formed together in an integrated manner and in the same material. The second closure means extends from the second wall. The first closure means and the second closure means cooperate with each other to facilitate selective joining of the first wall and the second wall together. The junction provides increased strength and rigidity, and reduced weight, compared to some junction systems of the prior art.
Patent NZ-713390-A (NZ)
Title: New compounds for treating, delaying and/or preventing a human genetic disorder such as myotonic dystrophy type 1 (dm1)
Inventor: AGUILERA DIEZ Maria Begoña
IPC: C12N15/113
Filed: 2012-04-23
Abstract: Discloses compounds comprising or consisting of the oligonucleotide sequence (NAG)m, wherein N is C or 5-methylcytosine and at least one occurrence of N is 5- methylcytosine and wherein m is 7, 8, 9, 10, 11, 12, 13, 14, or 15 and wherein no inosine nucleotide is present. Also discloses use of compound to treat dystrophy type 1, spino-cerebellar ataxia 8 and/or Huntington’s disease-like 2 caused by expansion of CUG repeats.
Patent NZ-721656-A (NZ)
Title: Human antibodies to pd-l1
Inventor: PAPADOPOULOS NICHOLAS
IPC: C07K16/30
Filed: 2015-01-23
Abstract: The present invention provides antibodies that bind to the T-cell co-inhibitor ligand programmed death-ligand 1 (PD-L1 ) protein, and methods of use. In various embodiments of the invention, the antibodies are fully human antibodies that bind to PD-L1. One such antibody is designated H2M8314N which comprises HCDR1 of GFTFDDYG, HCDR2 of IHWHGKRT, HCDR3 of VRGGMSTGDWFDP, LCDR1 of QSINSY, LCDR2 of VAS and LCDR3 of QQSYSTPPIT. In certain embodiments, the present invention provides multi-specific antigen-binding molecules comprising a first binding specificity that binds to PD-L1 and a second binding specificity that binds to a tumor cell antigen, an infected cell-specific antigen, or a T-cell co-inhibitor. In some embodiments, the antibodies of the invention are useful for inhibiting or neutralizing PD-L1 activity, thus providing a means of treating a disease or disorder such as cancer or viral infection.
Patent NZ-727548-A (NZ)
Title: Transponder module and access module for activating and configuring such transponder module
Inventor: SIX MARK
IPC: G07C1/22
Filed: 2015-07-27
Abstract: Methods are described for providing access to one or more transponder functions of sports timing transponder that is configured for transmitting a signal comprising a transponder identifier to a receiver of a timing system that is configured to determine the point in time that said transponder passes said receiver. The method may comprise: establishing a communication link between said transponder and an access module configured to determine time information; determining rights information stored in a memory of said transponder, said rights information comprising one or more access conditions for determining when a user of said transponder has a right to access at least part of said transponder functions; receiving time information from said access module; and, determining whether said user has a right to access at least part of said one or more transponder functions on the basis of at least part of said access conditions and said time information.
Patent NZ-732909-A (NZ)
Title: 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as adamts inhibitors for the treatment of osteoarthritis
Inventor: BREBION FRANCK
IPC: C07D403/06
Filed: 2015-12-18
Abstract: The present invention discloses compounds according to Formula (I), wherein R, R2, R3a, R3b, and Cy are as defined herein. The present invention discloses compounds inhibiting ADAMTS, methods for their production, pharmaceutical compositions comprising the same and methods for the prophylaxis and/or treatment of inflammatory conditions and/or diseases involving degradation of cartilage and/or disruption of cartilage homeostasis.
Patent NZ-743182-A (NZ)
Title: Heat pump system and method for controlling a heat pump system
Inventor: THORBURN JAN
IPC: F24D19/10
Filed: 2016-11-17
Abstract: Heat pump system comprising a heat medium circuit (210,220,230,240,250,310,320,410,420,430,440,450,460) in turn comprising a compressor (211), an expansion valve (232,242), at least one primary heat exchanging means (422,433,452) between a primary-side heat medium and a respective primary heat source or sink selected from outdoor air, a water body or the ground, at least one secondary heat exchanging means (314,315,316) between a secondary-side heat medium and a respective secondary heat source or sink selected from indoors air, pool water and tap water, and a control means (500). The invention is characterised in that the speed of the compressor can be controlled, in that an opening of the expansion valve is adjustable, in that the speed of the compressor is controlled, and in that an output temperature of heat medium flowing out from the expansion valve is controlled by controlling the opening of the expansion valve given the controlled speed of the compressor. The invention also relates to a method.